EpiPen Consumer, Competitor Claims Put On Separate Tracks In Multidistrict Litigation

(September 18, 2017, 1:40 PM EDT) -- TOPEKA, Kan. — The Kansas federal judge overseeing the new EpiPen multidistrict litigation on Sept. 14 ordered separate tracks for consumer class claims and an antitrust lawsuit (In Re:  EpiPen Marketing, Sales Practices and Antitrust Litigation, MDL Docket No. 2785, No. 17-md-2785, D. Kan.)....

Attached Documents

Related Sections